Literature DB >> 11766770

The involvement of angiotensins in the control of prostatic epithelial cell proliferation in the rat.

M Pawlikowski1, G Mełén-Mucha, S Mucha.   

Abstract

The effects of captopril (the inhibitor of the angiotensin-converting enzyme) and of angiotensins II and IV (3-8 fragment of angiotensin II) on cell proliferation of the prostatic epithelium was investigated in the rat. The incorporation of bromodeoxyuridine into cell nuclei was used as an index of cell proliferation. It was found that the treatment with captopril resulted in the suppression of prostatic epithelial cell proliferation. The antiproliferative effect of captopril was reversed (at least partially) by a simultaneous treatment with either angiotensin II or angiotensin IV. The effects of angiotensins were not blocked by the administration of losartan--AT1 angiotensin receptor blocker. These findings suggest the involvement of angiotensins in the control of prostatic growth, acting via the receptors different from the AT1-subtype (presumably via AT4 receptors).

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11766770

Source DB:  PubMed          Journal:  Folia Histochem Cytobiol        ISSN: 0239-8508            Impact factor:   1.698


  3 in total

1.  The effects of angiotensin peptides and angiotensin receptor antagonists on the cell growth and angiogenic activity of GH3 lactosomatotroph cells in vitro.

Authors:  Dorota Ptasinska-Wnuk; Slawomir A Mucha; Hanna Lawnicka; Jolanta Fryczak; Jolanta Kunert-Radek; Marek Pawlikowski; Henryk Stepien
Journal:  Endocrine       Date:  2012-03-23       Impact factor: 3.633

2.  Angiotensins inhibit cell growth in GH3 lactosomatotroph pituitary tumor cell culture: a possible involvement of the p44/42 and p38 MAPK pathways.

Authors:  Dorota Ptasinska-Wnuk; Hanna Lawnicka; Slawomir Mucha; Jolanta Kunert-Radek; Marek Pawlikowski; Henryk Stepien
Journal:  ScientificWorldJournal       Date:  2012-04-24

3.  Immunohistochemical detection of angiotensin AT 1 and AT 2 receptors in prostate cancer.

Authors:  Marek Pawlikowski; Radosław Minias; Marek Sosnowski; Krzysztof W Zieliński
Journal:  Cent European J Urol       Date:  2011-12-09
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.